Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Purple Biotech (PPBT) Leases (2019 - 2025)

Purple Biotech has reported Leases over the past 4 years, most recently at $467000.0 for Q4 2022.

  • Quarterly Leases fell 24.56% to $467000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $467000.0 through Dec 2022, down 24.56% year-over-year, with the annual reading at $467000.0 for FY2022, 24.56% down from the prior year.
  • Leases was $467000.0 for Q4 2022 at Purple Biotech, down from $505000.0 in the prior quarter.
  • Over five years, Leases peaked at $790000.0 in Q4 2020 and troughed at $108000.0 in Q2 2020.
  • The 4-year median for Leases is $562000.0 (2022), against an average of $520666.7.
  • Year-over-year, Leases crashed 65.27% in 2020 and then surged 555.56% in 2021.
  • A 4-year view of Leases shows it stood at $206000.0 in 2019, then surged by 283.5% to $790000.0 in 2020, then decreased by 21.65% to $619000.0 in 2021, then dropped by 24.56% to $467000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Leases are $467000.0 (Q4 2022), $505000.0 (Q3 2022), and $543000.0 (Q2 2022).